Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

A biomarker for risk stratification and disease severity assessment in SARS-CoV-2 infections has not yet been established. Point of care testing (POCT) of butyrylcholinesterase (BChE) enables early detection of systemic inflammatory responses and correlates with disease severity in sepsis and burns....

Full description

Bibliographic Details
Main Authors: Florian Espeter, David Künne, Lena Garczarek, Henning Kuhlmann, Annabell Skarabis, Aleksandar R. Zivkovic, Thorsten Brenner, Karsten Schmidt
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Diagnostics
Subjects:
COVID-19
sepsis
butyrylcholinesterase
point of care testing
Online Access:https://www.mdpi.com/2075-4418/12/9/2150

Internet

https://www.mdpi.com/2075-4418/12/9/2150

Similar Items